Search Knowledge Base

10 results for "antibodies-monoclonal"

A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma pubmed_article
Evidence Source PMID: 23158095
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis pubmed_article
Evidence Source PMID: 23737089
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis pubmed_article
Evidence Source PMID: 32671834
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria pubmed_article
Evidence Source 2014 PMID: 25356860
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis pubmed_article
Evidence Source 2015 PMID: 25915661
Interventions for chronic palmoplantar pustulosis pubmed_article
Evidence Source 2020 PMID: 31958161
From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19? pubmed_article
Evidence Source 2021 PMID: 33860730
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis pubmed_article
Evidence Source 2024 PMID: 38461503
Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38554937
The Efficacy and Safety of Folate Receptor α-Targeted Antibody-Drug Conjugate Therapy in Patients With High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2024 PMID: 39526448

Evidence Search Results semantic · quality-ranked

Live long and active: Polypeptide-mediated assembly of antibody variable fragments systematic_review pubmed_article
Quality: 47 2020 PMID: 33129938 DOI: 10.1016/j.addr.2020.10.017
Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review meta_analysis pubmed_article
Quality: 57 2017 PMID: 28414733 DOI: 10.1371/journal.pone.0175538
A consensus platform for antibody characterization. guideline guideline
Quality: 76 2025 PMID: 39690206 DOI: 10.1038/s41596-024-01095-8
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry. guideline guideline
Quality: 69 2026 PMID: 41182012 DOI: 10.1515/cclm-2025-1056
Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies. guideline guideline
Quality: 76 2025 PMID: 39617056 DOI: 10.1016/j.xphs.2024.11.024
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis meta_analysis pubmed_article
Quality: 63 2015 PMID: 25915661 DOI: 10.7326/M14-2957
**Navarese et al., 2015** | Ann Intern Med | Meta Analysis Navarese Eliano Pio, Kolodziejczak Michalina, ... Kelm Malte. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults W...
[Chinese expert consensus on screening and clinical application of monoclonal immunoglobulins(2025)]. guideline guideline
Quality: 65 2025 PMID: 40425449 DOI: 10.3760/cma.j.cn121090-20250108-00016
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis. guideline guideline
Quality: 65 2026 PMID: 41824923 DOI: 10.1212/NXI.0000000000200551
[Expert consensus on the clinical application of anti-rabies virus monoclonal antibody (2025 edition)]. guideline guideline
Quality: 65 2025 PMID: 41443678 DOI: 10.3760/cma.j.cn112338-20250808-00568
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma. guideline guideline
Quality: 65 2025 PMID: 41253088 DOI: 10.1016/j.ctrv.2025.103048

View full evidence search →